Cycle Vita Logo
  • About Cycle Vita
    • Product Support Overview
    • Meet the Team
    • Testimonials
  • Apps
    • Cycle Vita Low Pro™
  • Select a treatment
    • NITYR® (nitisinone) Tablets
    • JAVYGTOR™ (sapropterin dihydrochloride)
    • ORMALVI™ (dichlorphenamide) tablets
    • SAJAZIR™ (ICATIBANT) INJECTION
    • TASCENSO ODT® (fingolimod)
    • VENXXIVA™ (tiopronin) Delayed-Release Tablets
    • BAFIERTAM® (monomethyl fumarate) delayed-release capsules
    • HARLIKU™ (nitisinone) Tablets
    • PHYRAGO™ (dasatinib) Tablets
    • CAVHANZA™ (nilotinib) Orally Disintegrating Tablets (ODT)
  • Resources
  • News
  • Contact us

This site is intended for US consumers

Tag: VENXXIVA™ (tiopronin) Delayed-Release Tablets

New US product launch, VENXXIVA™ (tiopronin) Delayed-Release Tablets for the treatment of cystinuria

Cycle Pharmaceuticals Limited (Cycle) announced today the launch of VENXXIVA (tiopronin) Delayed-Release Tablets, for the treatment of cystinuria, approved by the US Food and Drug Administration (FDA).

Cycle Vita Logo
  • Follow us
YouTube Facebook
Cycle Pharma Logo
  • Contact us

© 2026 Cycle Pharmaceuticals Limited. All rights reserved.

Cycle Vita™ is a trademark of Cycle Pharmaceuticals Limited in the United States.

  • Compliance & Policies
  • Contact us
  • Modern Slavery Statement

By continuing to use this site you are accepting our cookie policy OK